SCHEMBL6608102

SCHEMBL6608102

COc1ccccc1-c1ccc(N(CC(=O)O)C(=O)OC(C)(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC13A5 Q86YT5 1/20 0.46
SLC6A9 P48067 1/20 0.43
GPR88 Q9GZN0 1/20 0.43
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
PDK1 Q15118 1/20 0.41
MME P08473 1/20 0.40
MMEL1 Q495T6 1/20 0.40
BRD4 O60885 1/20 0.39
CREBBP Q92793 1/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
EDNRB P24530 1/20 0.39
EDNRA P25101 1/20 0.39
DHODH Q02127 1/20 0.39
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6607125 0.85 GSTO1 (0.42) SLC6A9GPR88ALDH1A1MAPTMEN1
SCHEMBL219603 0.82 SMN1; SMN2 (0.49) ALDH1A1MEN1KMT2A
SCHEMBL7455182 0.81 LTB4R2 (0.45) SLC13A5SLC6A9GPR88PPARGPPARA
SCHEMBL4841484 0.80 KMT2A (0.43) MTNR1AMTNR1BMAPTMEN1KMT2A
SCHEMBL3660817 0.79 KEAP1 (0.49)
SCHEMBL3349318 0.78 MLYCD (0.41) MEN1KMT2ALTB4R2
SCHEMBL8469252 0.77 PPARG (0.42) PPARGPPARA
SCHEMBL895556 0.76 MLYCD (0.39) ALDH1A1MEN1KMT2A
SCHEMBL266144 0.75 MT-CO2 (0.46) PPARAALDH1A1MAPTMEN1KMT2A
SCHEMBL11648528 0.75 MLYCD (0.38) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1034164-B1 SUBSTITUTED BETA-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS MERCK & CO INC (US) 2004-05-19 EP disclosed
US-6645939-B1 Very late antigen-4 (VLA) integrin antagonists; antiallergens, antiasthmatics, and antiinflammatory agents; multiple sclerosis, autoimmune disease treatment MERCK & CO., INC. 2003-11-11 US disclosed
EP-1034164-A4 SUBSTITUTED BETA-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS MERCK & CO INC (US) 2001-07-11 EP disclosed
EP-1034164-A1 SUBSTITUTED BETA-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS Merck & Co., Inc. (US) 2000-09-13 EP disclosed
WO-1999026921-A1 SUBSTITUTED β-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS MERCK & CO., INC. (US) 1999-06-03 WO disclosed